Your browser doesn't support javascript.
loading
Histological Validation of FDG and PSMA-Targeted PET/CT Imaging in a Rare Tracheal Adenoid Cystic Carcinoma.
Sandach, Patrick; Seifert, Robert; Slama, Alexis; Theegarten, Dirk; Hautzel, Hubertus.
Affiliation
  • Sandach P; From the Department of Nuclear Medicine, University Hospital Essen.
  • Seifert R; From the Department of Nuclear Medicine, University Hospital Essen.
  • Slama A; Department of Thoracic Surgery and Thoracic Bronchoscopy, Ruhrlandklinik.
  • Theegarten D; Department of Pathology, University Hospital Essen, Essen, Germany.
  • Hautzel H; From the Department of Nuclear Medicine, University Hospital Essen.
Clin Nucl Med ; 48(1): e16-e18, 2023 Jan 01.
Article in En | MEDLINE | ID: mdl-36469074
ABSTRACT
ABSTRACT Adenoid cystic carcinomas are the second most common entity of tracheal malignancies, which have an overall incidence as low as only 0.2 in 100,000 persons per year. We present the case of a 64-year-old man with a histologically confirmed adenoid cystic carcinoma who sequentially underwent 18F-FDG PET/CT and 68Ga-PSMA-11 PET/CT within 1 day for staging 3 days before surgical resection of the tumor. Immunohistochemistry revealed PSMA expression of the tumor corroborating the PSMA PET findings.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tracheal Neoplasms / Carcinoma, Adenoid Cystic Limits: Humans / Male / Middle aged Language: En Journal: Clin Nucl Med Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tracheal Neoplasms / Carcinoma, Adenoid Cystic Limits: Humans / Male / Middle aged Language: En Journal: Clin Nucl Med Year: 2023 Document type: Article